Galanin Receptor Antagonists: A Potential Novel Pharmacological Treatment for Mood Disorders

Author： Ögren Sven Ove Kuteeva Eugenia Hökfelt Tomas Kehr Jan

ISSN： 1172-7047

Source： CNS Drugs, Vol.20, Iss.8, 2006-01, pp. : 633-654

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Potential of Adenosine A Receptor Antagonists in the Treatment of Movement Disorders

By Mally J.

CNS Drugs, Vol. 10, Iss. 5, 1998-11 ,pp. : 311-320

Adis International

Access to resources Recommend Favorite

Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders

By Bisaga A. Popik P. Bespalov A.Y. Danysz W.

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 10, 2000-10 ,pp. : 2233-2248

Informa Healthcare

Access to resources Recommend Favorite

mGluR antagonists and GABA agonists as novel pharmacological agents for the treatment of autism spectrum disorders

By Oberman Lindsay M

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 12, 2012-12 ,pp. : 1819-1825

Informa Healthcare

Access to resources Recommend Favorite

A novel galanin receptor

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 1, 1999-01 ,pp. : 105-108

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Potential for Endothelin Receptor Antagonists in Cardiovascular Disorders

By Spieker L.E. Noll G. Lüscher T.F.

American Journal of Cardiovascular Drugs, Vol. 1, Iss. 4, 2001-04 ,pp. : 293-303

Adis International

Access to resources Recommend Favorite